Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Psychopharmacology (Berl). 2015 Jan 27;232(13):2333–2342. doi: 10.1007/s00213-015-3868-3

Figure 2.

Figure 2

A) Effect of ceftriaxone treatment on the expression of GLT1a in the nucleus accumbens (NAc) and prefrontal cortex (PFC) compared to the respective saline-treated control groups presented in one figure. Representative immunoblot for GLT1a and GAPDH (loading control) expression along with quantitative analysis comparing ratios of GLT1a/GAPDH expression between saline- (served as 100%) and ceftriaxone treated P rats for the corresponding brain regions. Data are expressed as mean ± SEM. (*p<0.05; ****p<0.0001). B) Effect of ceftriaxone treatment on the expression of GLT1b in the nucleus accumbens (NAc) and prefrontal cortex (PFC) compared to the respective saline-treated control groups. Representative immunoblot for GLT1b and GAPDH (loading control) expression along with quantitative analysis comparing ratios of GLT1b/GAPDH expression between saline- (served as 100%) and ceftriaxone treated P rats for the corresponding brain regions. Data are expressed as mean ± SEM. (*p<0.05; ****p<0.0001).